Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Treasury Shares (2016 - 2026)

Dexcom has reported Treasury Shares over the past 9 years, most recently at $2.1 billion for Q1 2026.

  • Quarterly Treasury Shares rose 34.11% to $2.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.1 billion through Mar 2026, up 34.11% year-over-year, with the annual reading at $2.1 billion for FY2025, 31.85% up from the prior year.
  • Treasury Shares was $26.4 million for Q1 2026 at Dexcom, up from $7.7 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $26.4 million in Q1 2026 and troughed at $100000.0 in Q1 2022.
  • The 5-year median for Treasury Shares is $7.7 million (2025), against an average of $9.7 million.
  • Year-over-year, Treasury Shares plummeted 62.7% in 2022 and then soared 2002.14% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $595.0 million in 2022, then soared by 311.95% to $2.5 billion in 2023, then plummeted by 35.49% to $1.6 billion in 2024, then skyrocketed by 31.85% to $2.1 billion in 2025, then grew by 1.72% to $2.1 billion in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Treasury Shares are $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $1.8 billion (Q3 2025).